Status:
COMPLETED
Pilot to Evaluate VR-Therapy on People With Epilepsy and Related Anxiety
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
York University
Conditions:
Epilepsy
Anxiety Disorders and Symptoms
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Over 28% of people with epilepsy (PwE) struggle from at least one anxiety disorder, making anxiety the most common psychiatric comorbidity in this population. Despite the importance of treating anxiet...
Detailed Description
This pilot trial will be a mixed-methods, single-arm study with a target total recruitment of 5 participants. Each participant will take part in: a baseline interview, 12 to 14 days of the interventio...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Individuals with self-reported epilepsy aged 18-65
- Individuals that identify as having anxiety related to epilepsy
- Individuals that live in the city of Toronto
- Exclusion criteria:
- PwE who were ever told by a neurologist that they have photosensitive epilepsy or photoparoxysmal responses
- PwE that ever found, regardless of what a neurologist may have told them, that they have photosensitive epilepsy
- Individuals with open wounds on face
- Individuals with cervical conditions or injuries that would make it unsafe for them to use the VR headset
- Individuals who cannot speak and understand English
- PwE that started an antidepressant or antianxiety drug in the last twelve weeks
- PwE that started using medical marijuana in the last twelve weeks
- PwE that have tonic-clonic seizures more than once a month
- People with psychogenic non-epileptic seizures
- PwE that were ever told by a neurologist that stress might be a seizure trigger for them
- PwE that ever found, regardless of what a neurologist may have told them, that stress may be a seizure trigger for them
- Individuals that have been diagnosed with panic disorder
Exclusion
Key Trial Info
Start Date :
March 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2023
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05296057
Start Date
March 24 2023
End Date
September 20 2023
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Home based
Toronto, Ontario, Canada